Intervention Review

You have free access to this content

Amodiaquine for treating malaria

  1. Piero L Olliaro1,*,
  2. Paola Mussano2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 3 FEB 2003

DOI: 10.1002/14651858.CD000016

Database Title

Additional Information

How to Cite

Olliaro PL, Mussano P. Amodiaquine for treating malaria. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD000016. DOI: 10.1002/14651858.CD000016.

Author Information

  1. 1

    World Health Organization, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland

  2. 2

    Genthod, Switzerland

*Piero L Olliaro, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva 27, Geneva, Switzerland. olliarop@who.int.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (300K)Full (510K)
[Analysis 1.1]
Analysis 1.1. Comparison 1 Amodiaquine vs chloroquine in symptomatic participants, Outcome 1 Parasitological conversion.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Amodiaquine vs chloroquine in symptomatic participants, Outcome 2 Adverse events.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Amodiaquine vs chloroquine in asymptomatic participants, Outcome 1 Parasitological conversion on day 7.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Amodiaquine vs sulphadoxine-pyrimethamine in symptomatic participants, Outcome 1 Parasitological conversion.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Amodiaquine vs sulphadoxine-pyrimethamine in symptomatic participants, Outcome 2 Adverse events.
[Analysis 4.1]
Analysis 4.1. Comparison 4 AQ VS. CQ in symptomatic participants: Africa (sensitivity analysis), Outcome 1 Parasitological conversion.
[Analysis 5.1]
Analysis 5.1. Comparison 5 AQ vs SP in symptomatic participants: Africa (sensitivity analysis), Outcome 1 Parasitological conversion.
[Analysis 6.1]
Analysis 6.1. Comparison 6 AQ vs SP in symptomatic participants: Africa after 1990 (sensitivity analysis), Outcome 1 Parasitological conversion.
View Full Article (HTML) Summary (58K)Standard (300K)Full (510K)